Scholars Central

Conference abstractPublished 1 Oct 2012

Effect of the synthetic NC-1059 peptide on diffusion of riboflavin across an intact corneal epithelium

Authors: John M. Tomich

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

N C-1059 (KKKKAARVGLGITTVLVTTIGLGVRAA), a channel-forming peptide, alters ion transport across epithelia, transiently reducing barrier integrity of intact rabbit or chick corneal tissues, as well as cultured monolayers derived from human cornea (THCE). In cultured cells, NC-1059 causes a concentration-dependent increase in short circuit current, suggesting anion secretion and/or cation absorption, and an increase in transepithelial electrical conductance, suggesting paracellular permeation. These transient effects last < 90 min, with cell viability unaffected. During this period, the corneal epithelium is permeable to 5,6-Carboxyfluorescein and methotrexate, as well as FITC-labeled dextrans ranging in size from 10 to 70 kDa. Maximum transepithelial permeation appeared to reach a maximum approximately 30 min following a 5 min NC-1059 exposure. Histological examination of the ex vivo rabbit corneas revealed no apparent effect on cell ultrastructure, although the paracellular pathway was apparently opened. NC-1059 enhanced riboflavin (RF) diffusion across the corneal epithelium in chick embryos. RF irradiated with UV-A light is used clinically to cross-link corneal stroma collagen in patients with keratoconus. RF reaching a depth of 50 μm in stroma increased dramatically after exposure to NC-1059 for 10 minutes, reaching a plateau by 30 minutes. The concentrations of RF at stromal depths of 50, 100, and 150 μm were significantly greater in the presence of the peptide, approaching the magnitude of stromal permeation in preparations where the corneal epithelium was removed. These results support a model in which NC-1059 potentiates the movement of solutes across cell layers that typically form a barrier, blocking effective delivery of therapeutic compounds

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “John M. Tomich”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels